The U.S. National Cancer Institute does not currently endorse any foreign translations of PDQ® and no such endorsement should be inferred for the following translation.

Adult Non-Hodgkin’s Lymphoma: Treatment

General Information About Adult Non-Hodgkin’s Lymphoma

Adult non-Hodgkin’s lymphoma is a disease in which malignant (cancer) cells form in the lymph system.

The lymph system is part of the immune system and is made up of the following:


Because lymph tissue is found throughout the body, adult non-Hodgkin’s lymphoma can begin in almost any part of the body. Cancer can spread to the liver and many other organs and tissues.

Non-Hodgkin’s lymphoma can occur in both adults and children. Treatment for children, however, is different than treatment for adults. (Refer to the PDQ summary on Childhood Non-Hodgkin’s Lymphoma Treatment for more information.)

There are many different types of lymphoma.

Lymphomas are divided into two general types: Hodgkin’s lymphoma and non-Hodgkin’s lymphoma. This summary refers to the treatment of adult non-Hodgkin’s lymphoma. For information about other types of lymphoma, refer to the following PDQ summaries:


Age, gender, and a weakened immune system can affect the risk of developing adult non-Hodgkin’s lymphoma.

Anything that increases your risk of getting a disease is called a risk factor. Risk factors for adult non-Hodgkin’s lymphoma include the following:


Possible signs of adult non-Hodgkin’s lymphoma include fever, sweating, fatigue, and weight loss.

These and other symptoms may be caused by adult non-Hodgkin’s lymphoma. Other conditions may cause the same symptoms. A doctor should be consulted if any of the following problems occur:


Tests that examine the body and lymph system are used to help detect (find) and diagnose adult non-Hodgkin’s lymphoma.

The following tests and procedures may be used:


Certain factors affect prognosis (chance of recovery) and treatment options.

The prognosis (chance of recovery) and treatment options depend on the following:


Prognosis also depends on the level of LDH in the blood.


Stages of Adult Non-Hodgkin’s Lymphoma

After adult non-Hodgkin’s lymphoma has been diagnosed, tests are done to find out if cancer cells have spread within the lymph system or to other parts of the body.

The process used to find out the type of cancer and if cancer cells have spread within the lymph system or to other parts of the body is called staging. The information gathered from the staging process determines the stage of the disease. It is important to know the stage of the disease in order to plan treatment. The following tests and procedures may be used in the staging process:


Stages of adult non-Hodgkin's lymphoma may include E and S.

Adult non-Hodgkin's lymphoma may be described as follows:


The following stages are used for adult non-Hodgkin’s lymphoma:
Stage I

Stage I adult non-Hodgkin's lymphoma is divided into stage I and stage IE.


Stage II

Stage II adult non-Hodgkin's lymphoma is divided into stage II and stage IIE.


Stage III

Stage III adult non-Hodgkin’s lymphoma is divided into stage III, stage IIIE, stage IIIS, and stage IIIS+E.


Stage IV

In stage IV adult non-Hodgkin’s lymphoma, the cancer either:


Adult non-Hodgkin’s lymphomas are also described in terms of how fast they grow and the location of affected lymph nodes.

Indolent or aggressive:


Contiguous or noncontiguous:



Recurrent Adult Non-Hodgkin’s Lymphoma

Recurrent adult non-Hodgkin’s lymphoma is cancer that has recurred (come back) after it has been treated. The lymphoma may come back in the lymph system or in other parts of the body. Indolent lymphoma may come back as aggressive lymphoma. Aggressive lymphoma may come back as indolent lymphoma.


Treatment Option Overview

There are different types of treatment for patients with non-Hodgkin’s lymphoma.

Different types of treatment are available for patients with non-Hodgkin’s lymphoma. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. Before starting treatment, patients may want to think about taking part in a clinical trial. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment.

Clinical trials are taking place in many parts of the country. Information about ongoing clinical trials is available from the NCI Web site. Choosing the most appropriate cancer treatment is a decision that ideally involves the patient, family, and health care team.

Four types of standard treatment are used:
Radiation therapy

Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells. There are two types of radiation therapy. External radiation therapy uses a machine outside the body to send radiation toward the cancer. Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer. The way the radiation therapy is given depends on the type and stage of the cancer being treated.

Chemotherapy

Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the spinal column, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). To treat certain types of adult non-Hodgkin’s lymphoma that spread to the brain, CNS prophylaxis (chemotherapy given to kill cancer cells in the brain or spinal cord) may be used. The way the chemotherapy is given depends on the type and stage of the cancer being treated.

Combination chemotherapy is treatment using two or more anticancer drugs. Steroid drugs may be added, to relieve swelling and inflammation.

Biologic therapy

Biologic therapy is a treatment that uses the patient’s immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body’s natural defenses against cancer. This type of cancer treatment is also called biotherapy or immunotherapy.

Monoclonal antibody therapy is a type of biologic therapy used to treat adult non-Hodgkin's lymphoma. This is a cancer treatment that uses antibodies made in the laboratory, from a single type of immune system cell. These antibodies can identify substances on cancer cells or normal substances that may help cancer cells grow. The antibodies attach to the substances and kill the cancer cells, block their growth, or keep them from spreading. Monoclonal antibodies are given by infusion. They may be used alone or to carry drugs, toxins, or radioactive material directly to cancer cells. Monoclonal antibodies that have been joined to radioactive material are called radiolabeled monoclonal antibodies.

Watchful waiting

Watchful waiting is closely monitoring a patient’s condition without giving any treatment until symptoms appear or change.

New types of treatment are being tested in clinical trials. These include the following:
Vaccine therapy

Vaccine therapy is a type of biologic therapy that uses a substance or group of substances meant to cause the immune system to respond to a tumor and kill it.

High-dose chemotherapy with stem cell transplant

High-dose chemotherapy with stem cell transplant is a method of giving high doses of chemotherapy and replacing blood-forming cells destroyed by the cancer treatment. Stem cells (immature blood cells) are removed from the blood or bone marrow of the patient or a donor and are frozen and stored. After the chemotherapy is completed, the stored stem cells are thawed and given back to the patient through an infusion. These reinfused stem cells grow into (and restore) the body’s blood cells.

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.


Treatment Options by Stage


Indolent, Stage I and Contiguous Stage II Adult Non-Hodgkin’s Lymphoma

Treatment of indolent, stage I and contiguous stage II adult non-Hodgkin’s lymphoma may include the following:



Aggressive, Stage I and Contiguous Stage II Adult Non-Hodgkin’s Lymphoma

Treatment of aggressive, stage I and contiguous stage II adult non-Hodgkin’s lymphoma may include the following:



Indolent, Noncontiguous Stage II/III/IV Adult Non-Hodgkin’s Lymphoma

Treatment of indolent, noncontiguous stage II/III/IV adult non-Hodgkin’s lymphoma may include the following:


This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.


Aggressive, Noncontiguous Stage II/III/IV Adult Non-Hodgkin’s Lymphoma

Treatment of aggressive, noncontiguous stage II/III/IV adult non-Hodgkin’s lymphoma may include the following:


This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.


Adult Lymphoblastic Lymphoma

Treatment of adult lymphoblastic lymphoma may include the following:


This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.


Diffuse Small Noncleaved Cell/Burkitt Lymphoma

Treatment of adult diffuse small noncleaved cell/Burkitt lymphoma may include the following:


This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.


Treatment Options for Recurrent Adult Non-Hodgkin’s Lymphoma


Indolent, Recurrent Adult Non-Hodgkin’s Lymphoma

Treatment of indolent, recurrent adult non-Hodgkin’s lymphoma may include the following:


Treatment of indolent lymphoma that comes back as aggressive lymphoma may include the following:


This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.


Aggressive, Recurrent Adult Non-Hodgkin’s Lymphoma

Treatment of aggressive, recurrent adult non-Hodgkin’s lymphoma may include the following:


Treatment of aggressive lymphoma that comes back as indolent lymphoma may include the following:


This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.